John Canan

Insider Reports History

Location
Milwaukee, WI
Signature
/s/ Stephen Zamansky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Canan:

Company Role Class Num Shares Value Price $ Report Date Ownership
REV Group, Inc. Director Common Stock 65,390 $3,978,327 $60.84 03 Dec 2025 Direct
REV Group, Inc. Director Restricted Stock Unit 63,285 05 Dec 2024 Direct
Acasti Pharma Inc. Director Stock Options (Right to Buy) 45,000 28 Sep 2022 Direct

Insider Reports Filed by John Canan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REVG REV Group, Inc. 03 Dec 2025 1 $0 4 Director 05 Dec 2025, 20:40
REVG REV Group, Inc. 05 Dec 2024 1 $0 4 Director 09 Dec 2024, 20:11
REVG REV Group, Inc. 08 Dec 2023 1 $0 4 Director 12 Dec 2023, 19:13
REVG REV Group, Inc. 08 Dec 2022 1 $0 4 Director 12 Dec 2022, 15:05
ACST Acasti Pharma Inc. 28 Sep 2022 1 $0 4 Director 30 Sep 2022, 16:19
REVG REV Group, Inc. 09 Dec 2021 1 $0 4 Director 13 Dec 2021, 16:10
ACST Acasti Pharma Inc. 12 Nov 2021 1 $0 4 Director 16 Nov 2021, 15:16